<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="140148">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01276483</url>
  </required_header>
  <id_info>
    <org_study_id>REK-2010/2089</org_study_id>
    <nct_id>NCT01276483</nct_id>
  </id_info>
  <brief_title>Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients</brief_title>
  <official_title>Treatment Response Evaluation in Patients With Gastrointestinal Stromal Tumor Using PET/CT and DW MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare sensitivity, specificity and accuracy of PET, DW MRI
      and CT separately and combined for the evaluation of treatment response and progression-free
      survival in patients with GIST.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Radiologic-pathologic correlation</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Soft Tissue Neoplasms</condition>
  <condition>Gastrointestinal Tract</condition>
  <eligibility>
    <study_pop>
      <textblock>
        GIST patients suitable for medical treatment with targeted therapies.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Metastatic GIST patients suitable for TKI treatment

          -  GIST patients pursuing preoperative neoadjuvant TKI treatment

        Exclusion Criteria:

          -  Patients with contraindications to MRI and/or TKI treatment. For patients with renal
             failure, CT without intravenous contrast will be performed according to clinical
             practice.

          -  Patients who do not sign the consent paper for any reason or do not accept the study
             premises or patients who wish to withdraw for any reason during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mona-Elisabeth Revheim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital, Dept of Nuclear Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Therese Seierstad, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Oslo University Hospital, Institute for Cancer Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Øyvind S Bruland, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital, Dept of Oncology, The Norwegian Radium Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Knut Håkon Hole, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital, Department of Diagnostic Radiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lars Julsrud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital, Department of Diagnostic Radiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mona-Elisabeth Revheim, MD</last_name>
    <phone>+4723070840</phone>
    <email>mona.elisabeth.revheim@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Therese Seierstad, PhD</last_name>
    <phone>+4722781237</phone>
    <email>therese@radium.uio.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hosptal</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mona-Elisabeth Revheim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>January 22, 2016</lastchanged_date>
  <firstreceived_date>January 12, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Mona-Elisabeth Revheim</investigator_full_name>
    <investigator_title>Nuclear Medicine Phycisian</investigator_title>
  </responsible_party>
  <keyword>GIST</keyword>
  <keyword>Response Monitoring</keyword>
  <keyword>Functional Magnetic Imaging</keyword>
  <keyword>Positron Emission Tomography</keyword>
  <keyword>Computer Tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
    <mesh_term>Soft Tissue Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
